R&D Investment

Showing 1634 articles
Business

Marriott's Stock Soars, But Is It Flying Too Close to the Sun? Analysts Question Valuation After Stellar Run

Marriott International's shares have delivered impressive multi-year gains, but recent analysis suggests the hospitality giant's stock may now be trading at a significant premium. With a DCF model pointing to a 16% overvaluation and a P/E ratio exceeding industry peers, investors are debating whether the price fully reflects future growth or has outpaced fundamentals.

Business

Aeris Resources Surges on Strong Production, Debt Clearance; But Is the Rally Overextended?

Aeris Resources (ASX:AIS) shares have soared following a robust December quarter report featuring record copper-equivalent output and full repayment of a A$50 million debt facility. The operational momentum has fueled a dramatic 350% one-year shareholder return, yet analysts are divided on whether the stock's current price accurately reflects its underlying value or has overshot fundamentals.

Business

Coty's Deep Discount: A Value Trap or a Beauty Stock Bargain?

Coty Inc.'s shares have tumbled nearly 60% over the past year, trading at a steep discount to industry peers. While a discounted cash flow model suggests significant undervaluation, the prolonged weakness raises questions about the cosmetics giant's turnaround narrative and whether the market is missing a hidden gem.